Dr. Ian Flinn, Director of Hematologic Malignancies Research Program

Sarah Cannon, Research Institute & Jason Green, Chronic Myeloid Leukemia Patient Leukemia & Lymphoma Awareness Month is in September and Dr. Ian Flinn, will share information about how the patient benefits from clinical trials as well as the overall importance of them in terms of healthcare for the public. Patient Jason Green who was involved with the on such trial, will join Dr Flinn to talks about his courage and determination that led him to get involved with the clinical trials. September is Leukemia & Lymphoma Awareness Month Leading Researcher and Patient Team Up During to Discuss the Importance of Clinical Trials for Finding New Cancer Treatments As the cost of healthcare continues to skyrocket out of control, more and more people are learning how to become pro-active when it comes to their health. We’ve all heard about the standard things we should be doing like eating more fruits/veggies and less processed foods, exercising for at least 30 minutes a day, and making sure we don’t smoke or drink too much alcohol. But what about more alternative ideas–especially if you already have an illness that requires costly hospital and doctor visits–not to mention expensive drugs. One cutting edge option is finding out how to get involve during the “clinical trial” stage of an experimental drug. www.SarahCannonResearch.com This is something to try when you have a more serious disease like cancer. Leukemia & Lymphoma Awareness Month is in September, and Dr. Ian Flinn …